Adial Pharmaceuticals (ADIL) Competitors $0.35 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$0.36 +0.01 (+2.29%) As of 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ADIL vs. MAAQ, RVPH, ALLR, KZR, XCUR, CASI, DARE, TENX, CVKD, and CLSDShould you be buying Adial Pharmaceuticals stock or one of its competitors? The main competitors of Adial Pharmaceuticals include Mana Capital Acquisition (MAAQ), Reviva Pharmaceuticals (RVPH), Allarity Therapeutics (ALLR), Kezar Life Sciences (KZR), Exicure (XCUR), CASI Pharmaceuticals (CASI), Dare Bioscience (DARE), Tenax Therapeutics (TENX), Cadrenal Therapeutics (CVKD), and Clearside Biomedical (CLSD). These companies are all part of the "pharmaceutical products" industry. Adial Pharmaceuticals vs. Its Competitors Mana Capital Acquisition Reviva Pharmaceuticals Allarity Therapeutics Kezar Life Sciences Exicure CASI Pharmaceuticals Dare Bioscience Tenax Therapeutics Cadrenal Therapeutics Clearside Biomedical Mana Capital Acquisition (NASDAQ:MAAQ) and Adial Pharmaceuticals (NASDAQ:ADIL) are both small-cap pharmaceutical products companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, earnings, media sentiment, analyst recommendations, institutional ownership and profitability. Which has preferable earnings and valuation, MAAQ or ADIL? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMana Capital AcquisitionN/AN/AN/AN/AN/AAdial PharmaceuticalsN/AN/A-$13.20M-$1.05-0.33 Does the media favor MAAQ or ADIL? In the previous week, Adial Pharmaceuticals had 2 more articles in the media than Mana Capital Acquisition. MarketBeat recorded 2 mentions for Adial Pharmaceuticals and 0 mentions for Mana Capital Acquisition. Adial Pharmaceuticals' average media sentiment score of 1.45 beat Mana Capital Acquisition's score of 0.00 indicating that Adial Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Mana Capital Acquisition Neutral Adial Pharmaceuticals Positive Do analysts recommend MAAQ or ADIL? Adial Pharmaceuticals has a consensus target price of $8.00, suggesting a potential upside of 2,185.71%. Given Adial Pharmaceuticals' stronger consensus rating and higher possible upside, analysts plainly believe Adial Pharmaceuticals is more favorable than Mana Capital Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mana Capital Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Adial Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.00 Do insiders and institutionals hold more shares of MAAQ or ADIL? 68.4% of Mana Capital Acquisition shares are held by institutional investors. Comparatively, 16.4% of Adial Pharmaceuticals shares are held by institutional investors. 4.3% of Adial Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Is MAAQ or ADIL more profitable? Mana Capital Acquisition's return on equity of 0.00% beat Adial Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Mana Capital AcquisitionN/A N/A N/A Adial Pharmaceuticals N/A -191.31%-153.59% SummaryAdial Pharmaceuticals beats Mana Capital Acquisition on 7 of the 10 factors compared between the two stocks. Get Adial Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ADIL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ADIL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADIL vs. The Competition Export to ExcelMetricAdial PharmaceuticalsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.64M$237.81M$5.74B$10.24BDividend YieldN/A3.78%5.69%4.59%P/E Ratio-0.3341.2574.9326.41Price / SalesN/A4,870.38457.2789.16Price / CashN/A13.1925.8129.91Price / Book0.55126.0413.256.28Net Income-$13.20M-$90.99M$3.29B$270.38M7 Day Performance0.14%2.35%0.47%2.70%1 Month Performance-11.17%21.81%4.60%5.99%1 Year Performance-67.59%657.62%73.42%25.94% Adial Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADILAdial Pharmaceuticals2.9831 of 5 stars$0.35flat$8.00+2,185.7%-67.6%$7.64MN/A-0.3320Short Interest ↓MAAQMana Capital AcquisitionN/A$3.71+0.6%N/A+1,169.3%$30.14MN/A0.001RVPHReviva Pharmaceuticals3.1408 of 5 stars$0.44+0.7%$5.20+1,076.5%-63.1%$30.12MN/A-0.685News CoverageAnalyst ForecastALLRAllarity Therapeutics1.9522 of 5 stars$2.03+2.8%$9.00+344.2%-51.3%$29.90MN/A0.0010Short Interest ↑KZRKezar Life Sciences3.6152 of 5 stars$4.04-0.9%$9.00+123.0%-30.7%$29.54M$7M-0.4260News CoverageAnalyst UpgradeXCURExicure1.4515 of 5 stars$4.52-4.9%N/A+142.5%$29.28MN/A-1.1950Positive NewsCASICASI Pharmaceuticals3.7602 of 5 stars$2.37+1.5%$4.00+68.5%-68.2%$29.09M$28.54M-0.82180DAREDare Bioscience2.5562 of 5 stars$2.10-2.6%$10.00+377.3%-36.3%$28.24M$10K-0.9830Positive NewsShort Interest ↓TENXTenax Therapeutics2.2571 of 5 stars$6.21+3.6%$18.00+189.7%+60.4%$28.11MN/A-6.709CVKDCadrenal Therapeutics3.5163 of 5 stars$13.23-0.2%$32.00+142.0%+28.8%$27.09MN/A-1.494News CoveragePositive NewsShort Interest ↓Gap UpCLSDClearside Biomedical2.2172 of 5 stars$0.34-0.6%$4.20+1,120.9%-98.3%$27.01M$1.66M-0.9330Stock SplitGap Down Related Companies and Tools Related Companies Mana Capital Acquisition Alternatives Reviva Pharmaceuticals Alternatives Allarity Therapeutics Alternatives Kezar Life Sciences Alternatives Exicure Alternatives CASI Pharmaceuticals Alternatives Dare Bioscience Alternatives Tenax Therapeutics Alternatives Cadrenal Therapeutics Alternatives Clearside Biomedical Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ADIL) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adial Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adial Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ADIL Stock Alerts